Navigation Links
Par Pharmaceutical Reports Fourth Quarter and Full Year 2007 Results
Date:2/29/2008

om.

Non-GAAP Measures

Par prepares its consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (U.S. GAAP). In an effort to provide investors with additional information regarding the Company's results and to provide a meaningful year-over-year comparison of the Company's financial performance, the company sometimes uses non-GAAP financial measures as defined by the Securities and Exchange Commission. The differences between the U.S. GAAP and non-GAAP financial measures are reconciled in the attached. In presenting comparable results, the Company discloses non-GAAP financial measures when it believes such measures will be useful to investors in evaluating the Company's underlying business performance. Management uses the non-GAAP financial measures to evaluate the company's financial performance against internal budgets and targets. In addition, management internally reviews the results of the Company excluding the impact of certain items, as it believes that these non- GAAP financial measures are useful for evaluating the Company's core operating results and facilitating comparison across reporting periods. Importantly, the Company believes non-GAAP financial measures should be considered in addition to, and not in lieu of, U.S. GAAP financial measures. The Company's non-GAAP financial measures may be different from non-GAAP financial measures used by other companies.

About Par

Par Pharmaceutical Companies, Inc. develops, manufactures and markets generic drugs and innovative branded pharmaceuticals for specialty markets. For press release and other company information, visit http://www.parpharm.com.

Safe Harbor Statement

Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. To the extent any stateme
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Nastech Pharmaceutical Company Inc. to Hold Conference Call to Discuss Corporate Restructuring and Future Strategy on Monday, March 3, 2008
2. China Sky One Medical, Inc. to Acquire Heilongjiang Tianlong Pharmaceutical, Inc.
3. MAP Pharmaceuticals Reports 2007 Fourth Quarter and Year End Financial Results
4. KV Pharmaceutical Reports Record Revenues for Fiscal 2008 Third Quarter and Year-to-Date on a Preliminary Basis
5. Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board
6. Idenix Pharmaceuticals to Present at the SIGnificant Investment Options in Healthcare Conference
7. VIA Pharmaceuticals to Present at Susquehanna and Rodman & Renshaw Conferences on March 4, 2008
8. Lotus Pharmaceuticals Raises $5 Million in Private Placement
9. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
10. Transcept Pharmaceuticals to Present at the Susquehanna Financial Groups SIGnificant Investment Options in Healthcare Conference
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... ... July 01, 2015 , ... The federal court ... http://www.injurybeacon.com/levaquin/lawsuit/ ) has granted the Defendants’ Motion for Summary Judgment. According to an ... June 26th, the Court rejected the Plaintiff’s assertion that one manufacturer can ...
(Date:7/1/2015)... ... July 01, 2015 , ... SuiteRx, innovative leaders ... and compounding pharmacy operations, announces the most recent positioning of SuiteRx CEO, Nicholas ... event at the Venetian Las Vegas, Nevada. During this event, SuiteRx ...
(Date:7/1/2015)... VA (PRWEB) , ... July 01, 2015 , ... Dr. ... on Monday, July 6th on WAVY-TV’s The Hampton Roads Show to discuss non-invasive ... where diet and exercise fall short. , CoolSculpting fat reduction utilizes Cryolipolysis to ...
(Date:7/1/2015)... ... 01, 2015 , ... Summer recess has a whole new meaning. Thanks to ... with plastic surgery when they’re looking for a boost in self-esteem. According to the ... performed on patients ages 19 and younger in 2012, an increase from previous years. ...
(Date:7/1/2015)... Colorado) , ... - (PRWEB) July 01, 2015 , ... ... a nationwide virtual 5K on August 15-16th (MSG Keys’ birthday) in memory of her ... a highly decorated soldier and recipient of the Bronze Star Medal, died during a ...
Breaking Medicine News(10 mins):Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 2Health News:Levaquin Lawsuit Attorneys at Bernstein Liebhard LLP Comment on Decision to Grant Summary Judgment in Generic Drug Case 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 2Health News:Dr. Surya Challa of Chesapeake Vein Center and MedSpa Will be Featured on The Hampton Roads Show on WAVY-TV 3Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 2Health News:Top Manhattan Facial Plastic Surgeon Dr. Sam Rizk Comments on Teen Surgery Trends 3Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 2Health News:Wife of Fallen Special Forces Soldier to Host Nationwide ‘Virtual 5K’ for Charity 3
... BOTHELL, Wash., Sept. 18 SCOLR Pharma, Inc. ... September 15, 2009, the NYSE Amex LLC (the "Exchange") accepted ... disclosed listing deficiency as set forth in Section 1003(a)(iii) of ... Company,s failure to maintain stockholder,s equity of at least $6,000,000 ...
... - revenues increase by 21% over Fiscal ... are in Canadian dollars unless otherwise noted), , , ... (TSX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced ... 2009. , "We had a very successful year in terms ...
... , , Statement of Andy Stern, ... Andy Stern, President of the Service Employees ... right wing extremists to silence working families by attacking progressive individuals ... a moment of profound change for this country -- from kitchen ...
... ... of Hako-Med finding that Axiom Worldwide willfully infringed Hako-Med,s Horizontal Therapy patent and awarded ... the federal court issued another permanent injunction against Axiom Worldwide barring all EPS 8000 ... ...
... , LOUDOUN COUNTY, Va., Sept. 18 ... heath and wellness partner GlaxoSmithKline, and Men,s Health Network (MHN), ... prostate cancer awareness ribbons and disease awareness information cards to ... game at FedExField. Led by MHN staff, volunteers from GlaxoSmithKline, ...
... to alcohol or feelings of isolation remains unclear , FRIDAY, ... a link between suicide and rural communities that have higher ... that more bars mean more suicides because it does not ... suicide, about 20 percent are alcoholics, according to background information ...
Cached Medicine News:Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3Health News:SCOLR Pharma, Inc. Receives Notice from NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Health News:Bioniche Reports Fiscal 2009 Year-End Results 2Health News:Bioniche Reports Fiscal 2009 Year-End Results 3Health News:Bioniche Reports Fiscal 2009 Year-End Results 4Health News:Bioniche Reports Fiscal 2009 Year-End Results 5Health News:Bioniche Reports Fiscal 2009 Year-End Results 6Health News:Bioniche Reports Fiscal 2009 Year-End Results 7Health News:Bioniche Reports Fiscal 2009 Year-End Results 8Health News:Bioniche Reports Fiscal 2009 Year-End Results 9Health News:Bioniche Reports Fiscal 2009 Year-End Results 10Health News:Bioniche Reports Fiscal 2009 Year-End Results 11Health News:Bioniche Reports Fiscal 2009 Year-End Results 12Health News:Bioniche Reports Fiscal 2009 Year-End Results 13Health News:Bioniche Reports Fiscal 2009 Year-End Results 14Health News:Bioniche Reports Fiscal 2009 Year-End Results 15Health News:Working Women and Men Will Not Be Silenced by Right Wing Attack Dogs; SEIU Members and Other Working Americans Will Continue to Speak Out For the America We Believe In 2Health News:Axiom Worldwide Convicted of Infringing a Hako-Med Patent 2Health News:Men's Health Network, The Washington Redskins and GlaxoSmithKline Team Up for September's Prostate Cancer Awareness Month 2Health News:Suicides Higher in Rural Areas With Bars 2
(Date:7/1/2015)... -- Prismic Pharmaceuticals, Inc., a specialty pharmaceutical company developing ... the election of Joseph J. Krivulka and ... Directors. Commenting on the election of these ... and CEO of Prismic, stated, "We are delighted that ... have accepted our invitation to join Prismic,s Board of ...
(Date:7/1/2015)... , July 1, 2015 Dynatronics Corporation ... and marketer of rehabilitation and physical therapy products, ... private placement financing led by affiliates of Prettybrook ... investor focused on the healthcare industry. The financing ... growth and pursue potential strategic acquisitions.  ...
(Date:7/1/2015)... SHANGHAI , July 1, 2015 Qiming ... Hu to Managing Partner effective immediately. ... He has lead and participated in many Qiming healthcare ... leaders in the Chinese market. Qiming, s success in ... and he has distinguished himself with his outstanding advocacy ...
Breaking Medicine Technology:Joseph Krivulka and Martin Simonetti Join Board of Prismic Pharmaceuticals 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces Completion Of $4,025,000 Private Placement Led By Prettybrook Partners 3Qiming Announces the Promotion of William Hu to Managing Partner 2
... May 8, 2012  In a little more than ... Services Organization ( CalHIPSO ) has successfully developed ... throughout California implement Electronic Health Records (EHRs), considered ... of healthcare. This and other key milestones are ...
... A team of scientists led by Dr. Stanley Fricke of ... "Magnetic resonance imaging (MRI) sound barrier," a finding that could ... a new clinical study published this week in the peer-reviewed ... ultimate goal," said Dr. Fricke, "is to image small children ...
Cached Medicine Technology:CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years 2Children's National Medical Center Breaks MRI Speed Sound Barrier 2
The TBS-380 Fluorometer is an economical, sensitive fluorometer designed for quick, easy, and accurate fluorescent measurements....
... capsular bag in cases of damaged or ... for scleral fixation with suture. Robert J. ... recognized from his early experience using the ... need for greater stability when confronted with ...
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
Liquid, ready-to-use, bar-coded Olympus reagents are convenient, economical easy-to-use and reliable. This is one of 122 tests standardized for use on the Olympus AU400e, AU640e, AU2700, and AU5400 C...
Medicine Products: